BiomarkersHuman trial
Improved Detection of Mild Cognitive Impairment From Temporal Language Markers: I-CONECT Study
GSA 2025 Abstract
Abstract
Background: Mild Cognitive Impairment (MCI) is an early stage of Alzheimer’s disease, where timely detection can significantly improve intervention outcomes and quality of life. Language markers from routine conversations offer a promising, accessible method to identify MCI.

